CASE STUDY ONE: FUSION

To help you understand what we mean by Courageous research, we have created a series of case studies, outlining how we have solved unconventional business challenges with a breath of fresh air. Here is our Case Study One: Fusion.

THE BRIEF

Are infusion clinics really boring, stressful and time-consuming? The client wanted to be the market leader in biologics in gastroenterology. They had an in-home sub-cutaneous treatment while the standard of care was a hospital-administered infusion product.

Curious to know how we solved this brief? 

Send us an email and we will tell you all about our courageous methodology. Also find out more about our courageous workshops, where we come to you in person and show you why being courageous researchers is so important.  

Curious to know how we solved this brief? 

Send us an email and we will tell you all about our courageous methodology. Also find out more about our courageous workshops, where we come to you in person and show you why being courageous researchers is so important.  

CASE STUDY TWO: KEYSTONE

To help you understand even further what we mean by Courageous research, this is our Case Study Two: Keystone.

THE BRIEF

Our client had a portfolio of tumour markers competing with other investigations for use in oncology diagnosis and treatment monitoring.  The research objective was to decide whether to continue to focus their sales efforts on clinical scientists or change direction targeting physicians, and, if so, which ones and how to best approach them. 

Recreating the setting in which management and treatment decisions for lung cancer are made gave us the opportunity to understand first-hand the chain of events and the decision making process for biomarker testing, observing interactions and power relationships, identifying the key stakeholder in diagnostic and monitoring as well as involving clinical scientists in order to understand whether they have the knowledge, the ability to influence and the willingness to proactively take an educational role with physicians’ counterparts on how to use tumour markers.

The multi-phased methodology we designed for this study is particularly suited to real life situations where HCPs consult with each other as well as with external counterparts to make important treatment decisions. 

CASE STUDY THREE: FORGET-ME-NOT

To help you understand even further what we mean by Courageous research, here is our Case Study Three: Forget-me-not.

THE BRIEF

Our client's innovation team had partnered with a range of smart device manufacturers, to test various prototype devices developed to assist diabetes patients with their treatment adherence. The objectives were, first, to understand whether the prototype devices functioned as intended, and second, whether they had the capability of improving patient adherence in real life.

The client wanted to explore the value of these devices in two markets (UK and US), but without having to run a full clinical trial. Why avoid a trial? Because they take years to conduct; cost millions; and their results need to be reported, whether positive or negative.

Curious to know how we solved this brief? 

Send us an email and we will tell you all about the courageous methodology we designed, which successfully replaced the need for a clinical trial.

Also find out more about our courageous workshops, where we come to you in person and show you why being courageous researchers is so important.